Results 131 to 140 of about 11,489 (193)

Immunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization [PDF]

, 2013
Chang Li, CunXia Liu, DaYong Ren, JingQiang Ren, MaoPeng Wang, NingYi Jin, RongLan Yin, ShouWen Du, Xiao Li, YanQing Qin, Yi Li, YuHang Wang   +11 more
core   +1 more source

Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA). [PDF]

Vaccines (Basel)
Abidi S, Elhazaz Fernandez A, Seehase N, Hanisch L, Karlas A, Sandig V, Jordan I.   +6 more
europepmc   +1 more source

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells. [PDF]

PLoS Pathog, 2020
Peng C, Wyatt LS, Glushakow-Smith SG, Lal-Nag M, Weisberg AS, Moss B.   +5 more
europepmc   +1 more source

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

, 2006
Holger Ludwig, Yasemin Suezer, Zoe Waibler, Ulrich Kalinke, Barbara S. Schnierle, Gerd Sutter   +5 more
openalex   +1 more source

Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: Attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV [PDF]

, 2009
Koen K. A. Van Rompay, Kristina Abel, Patricia L. Earl, Pamela A. Kozlowski, Juliet Easlick, Joseph Moore, Linda Buonocore-Buzzelli, Kimberli A. Schmidt, Robert L. Wilson, Ian D. Simon, Bernard Moss, Nina F. Rose, John K. Rose, Marta L. Marthas   +13 more
openalex   +1 more source

Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. [PDF]

Signal Transduct Target Ther
Mayer L, Weskamm LM, Addo MM.
europepmc   +1 more source

Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells. [PDF]

Proc Natl Acad Sci U S A, 2020
Peng C, Moss B.
europepmc   +1 more source

Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. [PDF]

Signal Transduct Target Ther
Mayer L, Weskamm LM, Addo MM.
europepmc   +1 more source

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8⁺T-Cell Epitopes

, 2006
Nilu Goonetilleke, S. S. Moore, Len Dally, Nicola Winstone, Inese Cebere, Abdul Mahmoud, Susana Pinheiro, Geraldine M. Gillespie, Denise Scott Brown, Vanessa Loach, Joanna Roberts, Ana Guimarães‐Walker, Peter Hayes, Kelley Loughran, Carole Smith, Jeroen de Bont, Carl Verlinde, Danii Vooijs, Claudia Schmidt, Mark Boaz, Jill Gilmour, Pat Fast, Lucy Dorrell, Tomáš Hanke, Andrew J. McMichael   +24 more
openalex   +1 more source

P19-52 LB. Assessing and restructuring foreign gene insertion sites for enhanced stability of modified Vaccinia virus ankara recombinants expressing HIV genes [PDF]

, 2009
Linda S. Wyatt, Patricia L. Earl, Bernard Moss   +2 more
openalex   +1 more source